Table 1.
Patient demographics and baseline characteristics – ITT and mITT population
| ITT population twice‐daily tacrolimus → LCP‐Tacro (N = 44) | mITT population twice‐daily tacrolimus → LCP‐Tacro (N = 38) | |
|---|---|---|
| Age (yr), mean (SD) | 47.8 (13.68) | 48.3 (13.73) |
| Sex | ||
| Male | 34 (77.3) | 29 (76.3) |
| Female | 10 (22.7) | 9 (23.7) |
| Race | ||
| White | 34 (77.3) | 31 (81.6) |
| Black | 6 (13.6) | 4 (10.5) |
| Asian | 1 (2.3) | 0 |
| Other | 3 (6.8) | 3 (7.9) |
| Mean (SD) months from current kidney transplant to enrollment | 16.85 (14.45) | 15.63 (13.72) |
| Donor type, n (%) | ||
| Living | 15 (34.1) | 14 (36.8) |
| Deceased | 29 (65.9) | 24 (63.2) |
ITT, intent‐to‐treat; mITT, modified intent‐to‐treat.